Several studies have revealed that PD-L1 expression played a crucial role in enriching the anti-tumor response for pre-treatment melanoma specimens, and 30–40% of melanoma patients with high expression levels of PD-L1 had durable and objective responses [10]. Here, CD274 is linked to neoplasm.